# Assessment of the Safety and Efficacy of the Dermal Filler "mARG-01-17" in Facial Rejuvenation Therapy

> **NCT04643977** · NA · COMPLETED · sponsor: **Mesoestetic Pharma Group S.L.** · enrollment: 40 (actual)

## Conditions studied

- Facial Rejuvenation

## Interventions

- **DEVICE:** mARG-01-17 (mesohyal AGRIBENONE)

## Key facts

- **NCT ID:** NCT04643977
- **Lead sponsor:** Mesoestetic Pharma Group S.L.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-30
- **Primary completion:** 2018-12-18
- **Final completion:** 2018-12-18
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2020-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04643977

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04643977, "Assessment of the Safety and Efficacy of the Dermal Filler "mARG-01-17" in Facial Rejuvenation Therapy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04643977. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*